• Meetings
  • Regional Meeting, Cambridge 18 May 2018

Regional Meeting, Cambridge 18 May 2018

The 2018 Regional Meeting will be held at the Li Ka Shing Centre, Addenbrooke’s Hospital on Friday 18 May. The organisers are Dr Pippa Corrie and Dr Christine Parkinson of Cambridge University Hospitals NHS Foundation Trust.

CPD accreditation has been granted by the RCP, the RCS and BAPRAS.

We welcome posters at this meeting. Abstracts should be submitted to posters@melanomafocus.com, as soon as possible. Posters will be assessed during the day of the meeting and a prize awarded to the winner.

Earlybird discounts are available for a few more days, so don’t delay if you want to attend: follow this link for information on meeting fees and how to register.

For travel directions see this Summary and the Getting to CRUK CI guide.

Programme

From 08:45
Registration
09:30
Welcome and Introduction
09:35
Professor Marc Moncrieff, Norfolk and Norwich University NHS Foundation Trust:
Update on national melanoma database
09:50
Discussion
09:55 – 11:10
Session 1: Genetic predisposition, patterns of relapse and early detection of melanoma
09:55
Dr Erik Larsson Lekholm, Cancer Research UK Cambridge Institute:
Melanoma risk assessment and UV exposure
10:15
Dr Roy Rabbie, Wellcome Sanger Institute:
Prognostic factors and predictors of patterns of recurrence
10:30
Jonathan Wan, Cancer Research UK Cambridge Institute:
Detection of residual disease using ctDNA
10:45
Discussion
11:10
Coffee
11:30 – 13:00
Session 2: Immune checkpoint toxicity
11:30
Richard Jackson:
Patient experience – immune checkpoint GI toxicity
11:45
Dr Tim Raine, Cambridge University Hospitals NHS Foundation Trust:
Case presentation of immune checkpoint GI toxicity
12:05
Dr Trevor Lawley, Wellcome Sanger Institute:
Immune checkpoint GI toxicity and the microbiome
12:25
Discussion of management of GI checkpoint inhibitor toxicities
12:45
Controversies in metastatic melanoma systemic therapy 1:
Should pre-existing auto-immunity or treatment-induced irAEs influence subsequent use of checkpoint inhibitors?
13:00
Lunch and Poster Judging
14:00 – 15:30
Session 3: Melanoma trials
14:00
Guest speaker
Professor Jeffrey Weber, NYU Langone Medical Center, Perlmutter Cancer Center:
Adjuvant treatment of melanoma
14:40
Discussion
14:50
Controversies in metastatic melanoma systemic therapy 2:
How should we schedule targeted therapy and checkpoint inhibitors?
15:10
Professor Poulam Patel, Chair, NCRI Skin CSG:
Update on the NIHR melanoma trials portfolio
15:25
Discussion
15:30 – 16:30
Session 4: Surgical management of resectable disease
15:30
Mr Howard Peach, Leeds Teaching Hospitals NHS Trust:
Consensus SLNB
15:50
Discussion
16.30
Summary and Close




printer-friendly version